Skip to main content

Month: April 2025

Avance Gas Holding Ltd: Final extraordinary distribution of USD 0.74 per share

Hamilton, Bermuda. April 16, 2025 This refers to the Fourth Quarter 2024 Earnings Release announced on February 12, 2025. In that release, the Company stated that it would distribute a final dividend of approximately $0.70 per share upon receiving the remaining $34.2 million from Exmar in connection with the sale of the four Mid-Sized Gas Carriers (MGCs). We are pleased to announce that the final settlement with Exmar has been received. As a result, the Company will proceed with a final extraordinary distribution of $0.74 per share, totalling $56.7 million, of which $0.16 per share is return of capital and $0.58 per share is dividend. Key information of the extraordinary distribution is published in a separate press release. As announced in our third-quarter presentation on November 27, 2024, and reaffirmed in our fourth-quarter presentation...

Continue reading

Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance

Total sales growth of 11.6% at CER1, or 11.7% as reported, driven by all three therapeutic areas and including an increasing contribution from Iqirvo and Bylvay. Tovorafenib regulatory submission to EMA2 for pediatric low-grade glioma. Confirmation of full-year 2025 financial guidance.PARIS, FRANCE, 16 April 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents sales for the first quarter of 2025.  Q1 2025 % change % change  €m Actual CER1Oncology 655.0 8.5% 8.0%Neuroscience 193.5 8.0% 9.6%Rare Disease 70.3 78.4% 74.6%Total Sales 918.8 11.7% 11.6%       “Ipsen has delivered a strong start to 2025,...

Continue reading

Completion of Redemption of Senior Notes Due 2026

(Incorporated in the Cayman Islands with limited liability)(Stock Code: 975) ULAANBAATAR, Mongolia, April 16, 2025 (GLOBE NEWSWIRE) — This announcement is made by Mongolian Mining Corporation (the “Company”) pursuant to Rule 13.09(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (“Listing Rules”) and the Inside Information Provisions (as defined in the Listing Rules) of Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong). Reference is made to the announcement of the Company, dated 3 April 2025 (the “Announcement”), in relation to the Company’s notice to its holders of the Notes of its intention to redeem all of the outstanding Notes in full on 15 April 2025 (the “Redemption”). Unless otherwise defined, capitalized terms used herein shall have the...

Continue reading

Operational Update for the Quarter Ended 31 March 2025

(Incorporated in the Cayman Islands with limited liability) (Stock Code: 975) HONG KONG, April 16, 2025 (GLOBE NEWSWIRE) — The board of directors (the “Board”) of Mongolian Mining Corporation (the “Company”, together with its subsidiaries, collectively the “Group”) wishes to announce the unaudited operational update for the quarter ended 31 March 2025. The comparative figures for the quarter ended 31 March 2024 and the quarter ended 31 December 2024 are also disclosed in this announcement (if and as applicable). The Company is the largest internationally listed private mining company with operations focused on and located in Mongolia. The Group has consolidated a diversified business portfolio to develop and operate coking (metallurgical) coal, gold, copper, and other non-ferrous metals mining assets in southern and western regions...

Continue reading

Allegro Issues Statement

MANCHESTER, N.H., April 15, 2025 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (NASDAQ: ALGM) (“Allegro” or the “Company”) today issued the following statement regarding Onsemi’s withdrawal of its unsolicited proposal to acquire Allegro: As a general matter, the Board of Directors of Allegro (“the Board”) believes that public discourse around speculative transactions is not productive nor in the best interests of our stockholders. However, in light of current market speculation about our engagement with Onsemi, we believe it is important to provide stakeholders additional details about the process undertaken by the Board. As it would with any potentially credible outreach, the Board, in consultation with its independent financial and legal advisors, carefully reviewed and considered Onsemi’s proposals and...

Continue reading

XPENG Publishes 2024 Environmental, Social and Governance Report

GUANGZHOU, China, April 15, 2025 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today published its 2024 Environmental, Social and Governance Report (the “Report”). The Report highlights the Company’s achievements and continuous progress toward its sustainability objectives, along with its commitment to creating long-term value for society. 2024 ESG Report Highlights:ESG Achievements: XPENG has been awarded the highest MSCI ESG Rating of AAA, highlighting its leadership in environmental, social, and governance practices. Sustainable Energy Utilization: XPENG’s annual consumption of clean energy reached 25,718 MWh, complemented by photovoltaic power generation totaling 43,544 MWh, showcasing significant strides towards renewable...

Continue reading

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan1) in recurrent high-grade glioma (brain cancer), substantiating the patient benefit seen in the IPAX-1 study2. IPAX-Linz is a single-arm Phase 2 investigator-initiated trial (IIT). IPAX-Linz evaluates the safety, tolerability and preliminary efficacy of TLX101 therapy, in combination with external beam radiation therapy (EBRT). The target patient population is patients at first or second recurrence with high-grade gliomas (HGG), including glioblastoma. Treatment with TLX101 was well tolerated with no serious adverse events reported. IPAX-Linz demonstrated encouraging preliminary efficacy data,...

Continue reading

Fossil Group, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

RICHARDSON, Texas, April 15, 2025 (GLOBE NEWSWIRE) — Fossil Group, Inc. (NASDAQ: FOSL) (the “Company”) today announced that it is granting equity awards as a material inducement to the employment of the Company’s newly-hired Chief Digital Information Officer and General Manager EMEA, Antonio Carriero; Chief Commercial Officer, Joe Martin; and Chief Financial Officer, Randy Greben. In connection with the appointments of Carriero effective February 12, 2025, Martin effective February 17, 2025, and Greben effective March 17, 2025, the Company is granting Carriero an employment inducement award consisting of 100,000 time-based restricted stock units (“RSUs”), Martin an employment inducement award consisting of 129,581 RSUs and Greben an employment inducement award consisting of 150,000 RSUs. All three grants have an effective grant...

Continue reading

Theratechnologies Provides Update on Sale Process

MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that following careful consideration of the current circumstances, including the publicly announced proposal from Future Pak, the Board of Directors of the Company (the “Board”) has decided to further evaluate the potential sale of the Company through an open and non-exclusive process. In connection with this determination, the Board has authorized the special committee, consisting of independent and disinterested directors (the “Special Committee”), to oversee the process and make a recommendation to the full Board. To support this process, in addition to Barclays as financial advisor and Fasken as legal advisor, the Special Committee has...

Continue reading

U.S. Auto Manufacturer ECD Auto Design Reports Fourth Quarter and Full Year 2024 Financial Results; Revenues Increase 29% to $25 Million

2024 Revenue Growth of 29% and Gross Profit dollars increased 30%; Continued Execution of Growth Strategy to Expand Product Line Up, Fill the Factory and increase pace of cash conversionKISSIMMEE, Fla., April 15, 2025 (GLOBE NEWSWIRE) — U.S. Auto Manufacturer ECD Automotive Design, Inc. (Nasdaq: ECDA) (“ECD” or the “Company”), the world’s largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs and Toyota FJs, announced today its financial results for the fourth quarter and year ended December 31, 2024. Financial results and comparisons are based on re-stated numbers for 2023 and the first half of 2024. Full Year 2024 HighlightsRevenues increased 29% to $25.2 million in 2024, compared to $19.5 million in 2023. Growth was...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.